2023 Fiscal Year Final Research Report
Validation and Standardization of Psychosocial Assessment Tools in Epilepsy Care
| Project/Area Number |
21K16616
|
|---|
| Research Category |
Grant-in-Aid for Early-Career Scientists
|
| Allocation Type | Multi-year Fund |
|---|
| Review Section |
Basic Section 56010:Neurosurgery-related
|
|---|
| Research Institution | Tohoku University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2021-04-01 – 2024-03-31
|
| Keywords | てんかんリハビリテーション / 心理社会的問題 / てんかん包括医療 / リハビリテーション心理学 / てんかん心理社会尺度 |
|---|
| Outline of Final Research Achievements |
In epilepsy care, while standardization of medical (objective) assessment has been established, psychosocial (subjective) assessment have not been standardized. This project aimed to standardize psychosocial assessment methods by testing the reliability and validity of those assessment scales specific to patients with epilepsy.
The results demonstrated the validity and reliability of the quality of life (QOL) scale, disability acceptance, epilepsy self-stigma scale, self-efficacy scale for epilepsy management, and social support scale have been achieved. Additional analyses indicated that disability acceptance is an important factor for patients' QOL, and that positive interpersonal relationships, a sub-factor of social support, is a direct factor in improving QOL.
The findings of this study may lead to the development of a psychosocial scale battery specifically for epilepsy patients, which would enable assessing for psychosocial issues in patients in epilepsy care.
|
| Free Research Field |
てんかんリハビリテーション
|
| Academic Significance and Societal Importance of the Research Achievements |
本研究の意義は、包括的てんかんモニタリングユニット入院精査により診断や治療方針が確定されたてんかん患者を対象に、患者報告アウトカムの評価尺度である心理社会的尺度の妥当性・信頼性を検証したことにある。それにより、てんかん患者が抱える発作や発作以外の悩みについて多角的に評価またはモニタリングできるツールが確立された。この成果は、本邦の患者への貢献のみならず、てんかん領域の国内外の治療効果研究や評価ガイドラインへの評価基準として追加できることが期待される。
|
